Biogen to cut 1,000 jobs to save costs as Alzheimer's drug launch gathers pace

Biogen Inc said on Tuesday it expects to slash about 1,000 jobs, or about 11% of its workforce, under a fresh cost-cutting program as the company ramps up the launch of a new Alzheimer's disease drug in efforts to return to growth. Investors have pinned their hopes on Leqembi as the U.S…

#biogeninc #leqembi #sma #massachusetts #biogen #eisai #avonex #vumerity #spinraza #refinitiv